Evommune, Inc. (EVMN) — research page
US · us-cm-kg/NYSE/EVMN · as of 2026-11-08
Identity and listing
The issuer is Evommune, Inc., listed on the NYSE under ticker EVMN, with ISIN US30054Y1073. The LEI is not on the record. The security type is Corporate, the segment is not on the record, and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Delaware. The status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Evommune, Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | EVMN | source · 2026-11-08 |
| ISIN | US30054Y1073 | source · 2026-09-23 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 92 filings in the window 2025-11-08 to 2026-11-08, across 38 filing days. The filings comprise 42 directors' dealings, 20 regulatory filings, 11 corporate news, 8 prospectus, 8 results and 3 AGM/EGM filings. The median gap between filing days is 6 days. The latest filing is dated 2026-11-05 and is of type corporate news, 3 days before the record date. The NYSE median cadence gap is 6.0 days, with a median of 64.0 filings and a median latency of 4.0 days across 3,256 issuers. The sector median cadence gap is 6.0 days, with a median of 63.0 filings and a median latency of 4.0 days across 526 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 92 | 6 | 3 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
| 2026-11-04 | prospectus | 424B3 | 424B3 — 424B3 |
| 2026-11-04 | corporate_news | 8-K | 8-K — 8-K (items 1.01,3.02,7.01,8.01) |
| 2026-10-15 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
| 2026-10-01 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, as the latest annual report cover carries no auditor name tag. The auditor location is not on the record. The record holds no auditor changes.
Events and halts
The record holds listing lines dated 2025-11-04 and 2025-11-05. It holds no delisting, no name change, and no segment move; the segment move is not on the record. The domicile change is not on the record. The issuer is listed and not halted.
Orderability
The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 13 research houses: Cantor, Clear Street, Evercore ISI, HC Wainwright, Leerink Partners, Morgan Stanley, Needham, Oppenheimer, Raymond James, RBC Capital Markets, Stifel, UBS and William Blair.
| research house | analyst | source · read date |
|---|---|---|
| Cantor | Prakhar Aggarwal and Eric Schmidt | issuer page · 2026-11-11 |
| Clear Street | Kaveri Pohlman, PhD | issuer page · 2026-11-11 |
| Evercore ISI | Gavin Clark-Gartner and Umer Raffat | issuer page · 2026-11-11 |
| HC Wainwright | Mitchell Kapoor | issuer page · 2026-11-11 |
| Leerink Partners | Thomas Smith | issuer page · 2026-11-11 |
| Morgan Stanley | Chris Yu, Executive Director | issuer page · 2026-11-11 |
| Needham | Serge Belanger | issuer page · 2026-11-11 |
| Oppenheimer | Kostas Biliouris, PhD | issuer page · 2026-11-11 |
| Raymond James | Martin Auster | issuer page · 2026-11-11 |
| RBC Capital Markets | Brian Abrahams | issuer page · 2026-11-11 |
| Stifel | Alex Thompson | issuer page · 2026-11-11 |
| UBS | Alice Nettleton | issuer page · 2026-11-11 |
| William Blair | Matt Phipps, Ph.D. | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0002044725.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NYSE/EVMN (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://ir.evommune.com/stock-data/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NYSE/EVMN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US30054Y1073"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:fc60b980fbd1a43a.